Principal Street Partners’s Thermo Fisher Scientific TMO Stock Holding History

Principal Street Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-489	Closed	-$243K	–	380
2025 Q1	$243K	Buy	+489	New	+$265K	0.05%	197
2024 Q4	–	Sell	-764	Closed	-$423K	–	254
2024 Q3	$423K	Buy	764 +386	+102%	+$228K	0.07%	153
2024 Q2	$209K	Sell	378 -35	-8%	-$20.1K	0.04%	228
2024 Q1	$245K	Buy	+413	New	+$232K	0.05%	211
2023 Q4	–	Sell	-1,204	Closed	-$609K	–	234
2023 Q3	$609K	Buy	1,204 +672	+126%	+$358K	0.12%	124
2023 Q2	$278K	Sell	532 -162	-23%	-$87.4K	0.07%	184
2023 Q1	$400K	Sell	694 -6	-0.9%	-$3.38K	0.1%	142
2022 Q4	$386K	Sell	700 -22	-3%	-$11.7K	0.1%	145
2022 Q3	$366K	Buy	722 +9	+1%	+$5.04K	0.1%	142
2022 Q2	$388K	Buy	713 +171	+32%	+$94.1K	0.1%	141
2022 Q1	$320K	Sell	542 -66	-11%	-$37.9K	0.07%	176
2021 Q4	$406K	Buy	608 +91	+18%	+$56.8K	0.1%	153
2021 Q3	$296K	Buy	+517	New	+$284K	0.08%	155

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Principal Street Partners's TMO Position: Q2 2025 in Review

Principal Street Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 489 shares — an estimated $243K sold.

Principal Street Partners first reported a position in TMO in Q3 2021 and held it in 13 quarters. The position peaked at $609K in Q3 2023. 2,459 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Principal Street Partners reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Principal Street Partners sold 489 Thermo Fisher Scientific shares in Q2 2025, an estimated $243K.
Principal Street Partners first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 13 quarters.
Principal Street Partners's Thermo Fisher Scientific position peaked at $609K in Q3 2023.
2,459 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Principal Street Partners's 13F filing for Q2 2025, filed 14 Aug 2025.